Asthma is characterized by increased airway submucosal infiltration of T helper (Th) cells and myeloid cells that co-conspire to sustain a chronic inflammation. While recent studies have demonstrated that the myeloid basophils promote Th2 cells in response to various types of allergens, the underlying mechanisms are poorly understood. Here, we found for the first time that in a mouse model of allergic asthma basophils highly expressed OX40 ligand (OX40L) after activation. Interestingly, blockade of OX40-OX40L interaction suppressed basophils-primed Th2 cell differentiation in vitro and ameliorated ovalbumin (OVA)-induced allergic eosinophilic inflammation mediated by Th2 activation. In accordance, the adoptive transfer of basophils derived from mediastinal lymph nodes (MLN) of OVA-immunized mice triggered a robust Th2 response and eosinophilic inflammation in wild-type mice but largely muted in OX40(-/-) mice and mice receiving OX40L-blocked basophils. Taken together, our results reveal a critical role of OX40L presented by the activated basophils to initiate Th2 responses in an allergic asthma model, implicating OX40-OX40L signaling as a potential therapeutic target in the treatment of allergic airway inflammation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432274PMC
http://dx.doi.org/10.1074/jbc.M115.642637DOI Listing

Publication Analysis

Top Keywords

ox40 ligand
8
th2 responses
8
airway inflammation
8
allergic asthma
8
eosinophilic inflammation
8
th2
6
inflammation
5
basophils
5
basophil-associated ox40
4
ligand participates
4

Similar Publications

MiR-125b-5p ameliorates ox-LDL-induced vascular endothelial cell dysfunction by negatively regulating TNFSF4/TLR4/NF-κB signaling.

BMC Biotechnol

January 2025

Department of Emergency Medicine, Inner Mongolia People's Hospital, No. 20 Zhaowuda Road, Hohhot City, Inner Mongolia Autonomous Region, 010017, China.

Background: Oxidized low-density lipoprotein (ox-LDL)-induced endothelial cell dysfunction plays a crucial role in the progression of atherosclerosis (AS). Although miR-125b-5p is known to be involved in cardiovascular and cerebrovascular disorders, its function in ox-LDL-induced endothelial injury is still not well understood.

Methods: An in vitro AS cell model was established by exposing human umbilical vein endothelial cells (HUVECs) to 100 µg/mL ox-LDL for 24 h.

View Article and Find Full Text PDF

Background: As a member of the tumor necrosis factor (TNF) superfamily, tumor necrosis factor superfamily member 4 (TNFSF4) is expressed on antigen-presenting cells and activated T cells by binding to its receptor TNFRSF4. However, tumorigenicity of TNFSF4 has not been studied in pan-cancer. Therefore, comprehensive bioinformatics analysis of pan-cancer was performed to determine the mechanisms through which TNFSF4 regulates tumorigenesis.

View Article and Find Full Text PDF
Article Synopsis
  • Recent developments in understanding AD have highlighted the OX40 receptor's role, leading to new treatments that block the OX40 ligand, which have shown considerable improvement in patients with moderate to severe AD.
  • A thorough review of anti-OX40 treatments suggests they could be a promising option for AD management, but further studies are necessary to evaluate their long-term effectiveness in treating the disease.
View Article and Find Full Text PDF
Article Synopsis
  • Blocking IL-13 is effective for treating atopic dermatitis (AD), and new research suggests that targeting T cell costimulatory molecules like OX40 and OX40L could also be a beneficial treatment option.
  • This study investigates whether targeting CD30L might be an additional therapeutic avenue, by comparing it with existing targets like IL-13 and OX40L using single-cell RNA-seq and a murine model of AD.
  • Results showed that blocking CD30L effectively reduced disease symptoms in mice, indicating that targeting the CD30-CD30L pathway could be a promising future treatment for human atopic dermatitis, similar to targeting the OX40-OX40L pathway.
View Article and Find Full Text PDF

The tumor-infiltrating lymphocyte (TIL) is a crucial factor in controlling tumor growth. A therapeutic method activating TIL is desired for treating patients with metastatic tumors. Here, we show that treating a local tumor with a combination therapy of UV-irradiated hemagglutinating virus of Japan envelope (HVJ-E) plus agonist antibodies, including OX40, against T cell costimulatory molecules induces systemic anti-tumor effects in a T cell-dependent manner in multiple cancer cell lines.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!